Ronnie Yeager
Research Fellow, Emerging Therapeutic Platforms (Development Sciences) @AbbVie
Signup · Get unlimited contacts
WORK HISTORY
Research Fellow, Emerging Therapeutic Platforms (Development Sciences) @AbbVie
North Chicago, IL, US
EDUCATION
Western Washington University
B.S.
Indiana University Bloomington
Ph.D.
Indiana University Bloomington
M.S.
SKILLS
ABOUT RONNIE YEAGER
Research Fellow/Board Certified Toxicologist with over 15 years of drug development experience with small and large molecule programs across multiple therapeutic areas. Experienced in development and execution of non-clinical safety strategies, with focus on antibody drug conjugates (ADCs) and immuno-oncology programs across various formats/modalities. Have led and contributed to platform-related safety assessments and toxicity model development within oncology discovery. Supported compound advancement to FIH trials and regulatory filings/interactions (US and ex-US), including breakthrough therapy/accelerated approval pathways, through mid-late stage clinical development. Preclinical Safety lead for Emrelis™ (telisotuzumab-vedotin); AbbVie’s first FDA approval of an internally developed ADC solid tumor asset (lung cancer). Strong record of leading and collaborating within a matrixed organization both cross-functionally and cross-site (US and Europe).
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.